|
| leghisturl = http://thomas.loc.gov/cgi-bin/bdquery/z?d109:HR03889:@@@R | introducedin = House | introducedbill = | introducedby = Mark Souder (R–IN) | introduceddate = September 22, 2005 | committees = House Energy and Commerce, House Judiciary, House International Relations, House Transportation and Infrastructure | passedbody1 = House | passeddate1 = July 21, 2005 | passedvote1 = 257-171, , in lieu of | passedbody2 = Senate | passedas2 = | passeddate2 = July 29, 2005 | passedvote2 = Passed unanimous consent, in lieu of | conferencedate = December 8, 2005 | passedbody3 = House | passeddate3 = December 14, 2005 | passedvote3 = 251-174, , in lieu of | agreedbody3 = | agreeddate3 = | agreedvote3 = | agreedbody4 = | agreeddate4 = | agreedvote4 = | passedbody4 = Senate | passeddate4 = March 2, 2006 | passedvote4 = 89-10, , in lieu of | signedpresident = George W. Bush | signeddate = March 9, 2006 | unsignedpresident = | unsigneddate = | vetoedpresident = | vetoeddate = | overriddenbody1 = | overriddendate1 = | overriddenvote1 = | overriddenbody2 = | overriddendate2 = | overriddenvote2 = | amendments = | SCOTUS cases = }} The Combat Methamphetamine Epidemic Act of 2005 (CMEA) is federal legislation enacted in the United States on March 9, 2006, to regulate, among other things, retail over-the-counter sales of following products because of their use in the manufacture of illegal drugs: *ephedrine *pseudoephedrine *phenylpropanolamine (no longer OTC due to a proposed increased risk of stroke in younger women) Retail provisions of the CMEA include daily sales limits and 30-day purchase limits, placement of product out of direct customer access, sales logbooks, customer ID verification, employee training, and self-certification of regulated sellers. The CMEA is found as Title VII of the USA PATRIOT Improvement and Reauthorization Act of 2005 (H.R. 3199). The last provisions of the law took effect on 30 September 2006. ==Justification== Ephedrine, pseudoephedrine, and phenylpropanolamine are precursor chemicals used in the illicit manufacture of methamphetamine or amphetamine. They are also common ingredients used to make cough, cold, and allergy products. It was argued that the CMEA would curtail the clandestine production of methamphetamine. The U.S. Department of Justice claims that states that have enacted similar or more restrictive retail regulations have seen a dramatic drop in small clandestine labs.〔 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Combat Methamphetamine Epidemic Act of 2005」の詳細全文を読む スポンサード リンク
|